11:00 AM EDT, 10/08/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving higher Wednesday morning, rising 0.47% to 1,595.28 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion ( EVAX ) and biopharmaceutical company Cellectis ( CLLS ) , which surged 15% and 13%, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and accommodations booking site trivago (TRVG), which climbed 11% and 2.9%, respectively.

The decliners from continental Europe were led by petroleum refiner Equinor ( EQNR ) and semiconductor company Sequans Communications ( SQNS ) , which fell 3.3% and 0.6%, respectively. They were followed by oil and gas company TotalEnergies (TTE) and biopharmaceutical company argenx (ARGX), which were off 0.5% each.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and biotech company Autolus Therapeutics ( AUTL ) , which advanced 29% and 5.3%, respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) and lender Lloyds Banking Group ( LYG ) , which rose 2.8% and 2.7%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which dropped 11% and 8.6%, respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and oil and gas company Shell (SHEL), which were down 1.9% and 1%, respectively.